Portfolio of Coronavirus Vaccine Stocks

The following table includes 11 coronavirus vaccine stocks. Note: Phizer (PFE) is omitted because of problems reading price data from Alpha Vantage.

11 Coronavirus Vaccine Stocks

& Monthly Returns

& Snapshot

Recent Prices
& Trendline Chart

Heat BiologicsHTBX
Inovio PharmaceuticalsINO
Johnson & JohnsonJNJ
Price charts from Alpha Vantage as of most recent close.

Portfolio Values

To inspect the performance of the Coronavirus Vaccine Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 9 stocks included in the portfolio computations are: ALT, AZN, GSK, HTBX, INO, JNJ, NVAX, SNY and VXRT. The current value of the portfolio assumes that $1,111.11 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. BNTX and MRNA were excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $13,907. The percent return is 39.07%. The annualized return is 11.62%.

Portfolio Value Chart for Last 100 Daily Closes

Values of User-Selected Sample Portfolios: Discover the Most and Least Profitable Sample Portfolios

See Portfolio of Coronavirus Stocks.

See Portfolio of Coronavirus Lockdown Stocks.

See Portfolio of Coronavirus Treatment and Vaccine Stocks

Related Portfolios

Portfolio of Medical Device Maker Stocks

Portfolio of Medical Diagnostic Stocks

Portfolio of Medical Equipment Stocks

Portfolio of Medical Instruments and Supplies Stocks

Portfolio of Medical Laboratory and Research Stocks

Portfolio of Telemedicine Stocks

Portfolio of Vaccine Stocks